Novel approaches for reducing free light chains in patients with myeloma kidney
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel approaches for reducing free light chains in patients with myeloma kidney
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 8, Issue 4, Pages 234-243
Publisher
Springer Nature
Online
2012-02-21
DOI
10.1038/nrneph.2012.14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Cut-off Dialysis Membranes: Current Uses and Future Potential
- (2011) Bertrand Gondouin et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progression
- (2011) Jatin Shah et al. CANCER
- Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma Kidney
- (2011) C. A. Hutchison et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The pathogenesis and diagnosis of acute kidney injury in multiple myeloma
- (2011) Colin A. Hutchison et al. Nature Reviews Nephrology
- Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study
- (2011) A. Granger Vallee et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Aggregated serum free light chains may prevent adequate removal by high cut-off haemodialysis
- (2011) S. Harding et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Renal Improvement in Myeloma with Bortezomib plus Plasma Exchange
- (2011) Brian L. Burnette et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment
- (2010) Ulrike Klein et al. ANNALS OF HEMATOLOGY
- Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency
- (2010) Patrizia Tosi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Immunoglobulin light chains activate nuclear factor- B in renal epithelial cells through a Src-dependent mechanism
- (2010) W.-Z. Ying et al. BLOOD
- The efficacy and safety of lenalidomide plus dexamethasone in relapsed and/or refractory multiple myeloma patients with impaired renal function
- (2010) Meletios Dimopoulos et al. CANCER
- Meeting the Unmet Needs in Anticoagulant Therapy
- (2010) EUROPEAN JOURNAL OF HAEMATOLOGY
- Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study
- (2010) Javier De La Rubia et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Light Chain–Induced Acute Renal Failure Can Be Reversed by Bortezomib-Doxorubicin-Dexamethasone in Multiple Myeloma: Results of a Phase II Study
- (2010) Heinz Ludwig et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group
- (2010) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents
- (2010) Maria Roussou et al. LEUKEMIA RESEARCH
- Reversal of dialysis-dependent renal failure in patients with advanced multiple myeloma: single institutional experiences over 8 years
- (2009) Kosei Matsue et al. ANNALS OF HEMATOLOGY
- Autologous Hematopoietic Stem Cell Transplantation May Reverse Renal Failure in Patients with Multiple Myeloma
- (2009) Gaurav C. Parikh et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis
- (2009) C. A. Hutchison et al. Clinical Journal of the American Society of Nephrology
- Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients
- (2009) Martina Kleber et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA
- (2009) Fortunato Morabito et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study
- (2009) Meletios A. Dimopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Serum Free-Light Chain Removal by High Cutoff Hemodialysis: Optimizing Removal and Supportive Care
- (2008) Colin A. Hutchison et al. ARTIFICIAL ORGANS
- Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
- (2008) C. A. Hutchison et al. Clinical Journal of the American Society of Nephrology
- Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?
- (2008) Colin A Hutchison et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains
- (2008) N. Leung et al. KIDNEY INTERNATIONAL
- Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study
- (2008) J F San-Miguel et al. LEUKEMIA
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
- (2008) A Dispenzieri et al. LEUKEMIA
- Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens
- (2008) Maria Roussou et al. LEUKEMIA & LYMPHOMA
- European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): A randomised control trial
- (2008) Colin A Hutchison et al. Trials
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started